On the recordApril 25, 2022
In light of the decision by CMS, do you question the FDA's decisionmaking regarding Aduhelm's accelerated approval?
Source
congress.govIn light of the decision by CMS, do you question the FDA's decisionmaking regarding Aduhelm's accelerated approval?
Senator Collins questions the FDA's decision-making after CMS's coverage determination.
Share & report
More from Susan Collins
These are not only the right thing to do for humanitarian reasons, but they are incredible instruments of soft power.